I feel IND will send this much higher - more in the 20x range. http://www.marketwired.com/press-release/entest-biomedical-inc-recruits-salk-institute-researcher-lead-cancer-stem-cell-program-pinksheets-entb-1930288.htm http://www.linkedin.com/pub/christine-ichim/34/352/174 I also think this will happen by the end of the year. Dr. Ichim has the credentials to do it. $ENTB$